Onconetix

(NASDAQ) ONCO

Current Price$1.02

Market Cap$3.77M

Since IPO (2022)-100%

5 YearN/A

1 Year-100%

1 Month-74%

Onconetix Financials at a Glance

Market Cap

$3.77M

Revenue (TTM)

$735.20K

Net Income (TTM)

-$9.70M

EPS (TTM)

-$435.73

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.02

Volume

399,950.198

Open

$1.08

Price

$1.02

Volume

399,950.198

Open

$1.08

Previous Close

$1.02

Daily Range

$0.95 - $1.11

52-Week Range

$0.91 - $270.00

Estimated Earnings Date

Aug 17, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.02

Volume

399,950.198

Open

$1.08

Previous Close

$1.02

Daily Range

$0.95 - $1.11

52-Week Range

$0.91 - $270.00

Estimated Earnings Date

Aug 17, 2026

ONCO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Onconetix

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Allan White, MBA

Website

www.onconetix.com

Headquarters

Cincinnati, OH 45202, US

ONCO Financials

Key Financial Metrics (TTM)

Gross Margin

80%

Operating Margin

-9%

Net Income Margin

-13%

Return on Equity

-119%

Return on Capital

-58%

Return on Assets

-65%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.77M

Shares Outstanding

3.69M

Volume

399.95K

Avg. Volume

1.21M

Financials (TTM)

Gross Profit

$632.91K

Operating Income

-$6.34M

EBITDA

-$13.27M

Operating Cash Flow

-$9.68M

Capital Expenditure

$0.00

Free Cash Flow

-$9.68M

Cash & ST Invst.

$5.22M

Total Debt

$48.77K

Onconetix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$21.46K

-78.9%

Gross Profit

-$1.66K

-103.6%

Gross Margin

-7.71%

N/A

Market Cap

$3.77M

N/A

Market Cap/Employee

$313.78K

N/A

Employees

N/A

Net Income

-$4.21M

+50.7%

EBITDA

-$4.21M

+49.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$3.72M

+135.6%

Total Debt

$289.92K

-96.8%

Accounts Receivable

$43.73K

-35.4%

Inventory

$137.64K

-11.6%

Long Term Debt

$18.31K

N/A

Short Term Debt

$271.61K

-97.0%

Return on Assets

-65.41%

N/A

Return on Invested Capital

-57.65%

N/A

Free Cash Flow

-$2.12M

-6.1%

Operating Cash Flow

-$2.12M

-6.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.00-1.36%

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

SLXNSilexion Therapeutics Ltd.

SLXNSilexion Therapeutics Ltd.$3.13+1.29%

INDPIndaptus Therapeutics, Inc.

INDPIndaptus Therapeutics, Inc.$3.58+0.28%

ENVBEnveric Biosciences, Inc.

ENVBEnveric Biosciences, Inc.$1.53-7.83%

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.50-26.47%

SPRCSciSparc Ltd.

SPRCSciSparc Ltd.$8.55-8.16%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$124.57+0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

ASTSAST SpaceMobile

ASTSAST SpaceMobile$82.41-0.16%

Questions About ONCO

What is the current price of Onconetix?

Onconetix is trading at $1.02 per share.

What is the 52-week range for Onconetix?

Over the past 52 weeks, Onconetix has traded between $0.91 and $270.00.

How much debt does Onconetix have?

As of the most recent reporting period, Onconetix reported total debt of $289.92K.

How much cash does Onconetix have on hand?

Onconetix reported $3.72M in cash and cash equivalents in its most recent financial results.

What is Onconetix’s dividend yield?

Onconetix does not currently have a dividend yield.

Onconetix

Onconetix Financials at a Glance

ONCO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Onconetix

ONCO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Onconetix Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ONCO

What is the current price of Onconetix?

What is the 52-week range for Onconetix?

How much debt does Onconetix have?

How much cash does Onconetix have on hand?

What is Onconetix’s dividend yield?

Premium Investing Services